Talking Shots with Science Sam and 鶹ֱapp Professor Christina Guzzo (Part 1)
Canada has been ramping up its COVID-19 vaccination campaign in recent weeks, with . But hesitancy about vaccine safety persists among some individuals.
In the first segment of a three-part series, Samantha Yammine – a neuroscientist, science communicator and University of Toronto alumna otherwise known as – talks to Christina Guzzo, an assistant professor in the department of biological sciences at 鶹ֱapp Scarborough, about the risks and benefits of getting the COVID-19 shot.
Guzzo explains that vaccinated people have far lower rates of reinfection compared to those who contracted COVID-19. The risk of experiencing long-term effects from COVID-19 also far outweigh the chance of experiencing extremely rare complications from the vaccine, she says.
“We don’t have enough science and data and evidence to understand who might have a long-term effect from COVID-19,” Guzzo says, “so vaccination provides an additional benefit where it protects you from ... taking a chance and [saying], ‘Might I be the person who has a neurological impact from a COVID-19 infection?’”
Guzzo adds that the risks surrounding the COVID-19 vaccine are both low and acceptable, compared to the daily risks we face in the normal course of our lives.